How Is the Pharmaceutical Pipeline Targeting Novel Mechanisms for Ocular Pain Relief?
Pharmaceutical pipeline for chronic ocular surface pain — the novel mechanisms investigation — the development of therapeutic agents targeting TRPV1, TRPM8, purinergic P2X3 receptors, substance P/CGRP neuropeptide pathways, and central sensitization pharmacological targets specifically for chronic ocular surface pain — representing the most commercially significant...
0 Kommentare 0 Anteile 195 Ansichten 0 Vorschau